[Long-term management of anemia in chronic inflammatory bowel disease].
The development of a stepwise therapy, as detailed below, can be administered to the mostly young patients with Crohn's disease and ulcerative colitis on an out-patient basis and appropriate to their needs. This is true not only for the activity of the disease, but also for extraintestinal manifestations. The numerous variations in the stepwise anti-inflammatory therapy of chronic inflammatory bowel disease, but also in the substitution therapy of deficiency states and the therapy of accompanying extraintestinal diseases provide the gastroenterologist with the possibility of a long-term treatment tailored to the needs of the individual patient.
Mickisch
O
O
Gastroenterologische Schwerpunktpraxis, Mannheim, Germany.
Baniewicz
W
W
Lutz-Vorderbrügge
A
A
Schreiber
S
S
Küppers
B
B
D018798:Anemia, Iron-Deficiency / Q000209:etiology / Q000628:therapy*; D003093:Colitis, Ulcerative / Q000150:complications / Q000628:therapy*; D003424:Crohn Disease / Q000150:complications / Q000628:therapy*; D004921:Erythropoietin / Q000008:administration & dosage*; D005290:Ferric Compounds / Q000008:administration & dosage*; D005296:Ferrous Compounds / Q000008:administration & dosage*; D006801:Humans; D011994:Recombinant Proteins
D005290:Ferric Compounds; D005296:Ferrous Compounds; D011994:Recombinant Proteins; D004921:Erythropoietin